Quince Therapeutics, Inc. (QNCX)
1.22
-0.01
(-0.81%)
USD |
NASDAQ |
May 06, 16:00
1.23
+0.01
(+0.82%)
After-Hours: 04:48
Quince Therapeutics Cash from Investing (Quarterly) : 8.071M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | -0.338M |
| Ocular Therapeutix, Inc. | -4.662M |
| Gossamer Bio, Inc. | 73.16M |
| Ernexa Therapeutics, Inc. | -0.015M |
| Acurx Pharmaceuticals, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.48M |
| Cash from Financing (Quarterly) | 2.034M |
| Free Cash Flow | -41.78M |
| Free Cash Flow Per Share (Quarterly) | -1.882 |
| Free Cash Flow to Equity (Quarterly) | -10.96M |
| Free Cash Flow to Firm (Quarterly) | -10.48M |
| Free Cash Flow Yield | -229.9% |